Figure 1: Observed changes of 9 metabolites in the sera of CHB, HBV-associated cirrhosis and HBV-associated HCC patients (N = 136, 104, 95 respectively). Serum concentrations of lipid metabolites were detected using UPLC-TQMS. | Scientific Reports

Figure 1: Observed changes of 9 metabolites in the sera of CHB, HBV-associated cirrhosis and HBV-associated HCC patients (N = 136, 104, 95 respectively). Serum concentrations of lipid metabolites were detected using UPLC-TQMS.

From: Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients

Figure 1

(a–f) LysoPC and PC: lysoPC a C18:0, lysoPC a C18:2, lysoPC a C20:3, lysoPC a C20:4, lysoPC a C24:0, PC ae C42:1 respectively. (g,h) AC: AC C18:2, AC C3-OH. (i) SM: SM C24:1. P values were calculated from non-parametric Kruskal-Wallis test and adjusted by the FDR method. *p < 0.05; **p < 0.01; ***p < 0.001 when compared to CHB. #p < 0.05; ##p < 0.01; ###p < 0.001 when compared to HBV-associated cirrhosis.

Back to article page